Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Few shares left until 0.54

<< Previous

Bullboard Posts

Next >>

Comment by WalkingDead01on Feb 05, 2021 11:41am

91 Views

Post# 32484102

RE:RE:Few shares left until 0.54

Red :

no problem for the two blocks at $ 1.90 and $ 1.95 because these are my actions. I placed these sales to prevent them from being used for the Shorts. As soon as we leave for the moon, I'll withdraw my sales.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks